1,736
Participants
Start Date
June 1, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2028
Docetaxel
Docetaxel is a taxoid antineoplastic agent used in the treatment of breast cancer
Carboplatin
Carboplatin is a deoxyribonucleic acid (DNA) synthesis inhibitor which binds to DNA, inhibits replication and transcription and induces cell death.
Epirubicin
Epirubicin is an antineoplastic agent derived from doxorubicin.Epirubicin, like doxorubicin, exerts its antitumor effects by interference with the synthesis and function of DNA and is most active during the S phase of the cell cycle.
Cyclophosphamide
Cyclophosphamide is a nitrogen mustard that exerts its anti-neoplastic effects through alkylation.
RECRUITING
Breast cancer institute of Fudan University Cancer Hospital, Shanghai
Fudan University
OTHER